Register for Pediatric Patients With Antiphospholipid Syndrome (APS): European Project Extended Internationally Study
Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY
The purpose of this study is to gather information about causes and treatment of Antiphospholipid Syndrome.
Eligibility
Participation Requirements
Sex: All
Minimum Age: Newborn
Maximum Age: 18
Healthy Volunteers: f
View:
• 18 years of age or younger at the onset of disease
• Presence of Vascular Thrombosis
• UC Davis patient
• Presence of at least one Laboratory criteria including: Anticardiolipin antibody, Anti-B glycoprotein-I antibody or Lupus anticoagulant in plasma
Locations
United States
California
UC Davis Medical Center
RECRUITING
Sacramento
Contact Information
Primary
Lavjay Butani
(916) 734-8118
Time Frame
Start Date: 2006-09
Estimated Completion Date: 2040-01
Participants
Target number of participants: 50
Related Therapeutic Areas
Sponsors
Collaborators: Ministry of Higher Education, Science and Technology, Solvenia
Leads: University of California, Davis